🔗 Share this article

Treasury head Rachel Reeves has announced she is preparing "targeted measures to tackle cost of living pressures" in the upcoming financial statement.

In comments to the BBC, she stated that curbing price rises is a collective responsibility of both the administration and the Bank of England.

The UK's inflation rate is expected to be the most elevated among the Group of Seven advanced economies this calendar year and next.

Potential Utility Cost Measures

It is understood the administration could intervene to lower energy bills, for example by reducing the present 5% level of value-added tax charged on energy.

An additional option is to reduce some of the government charges currently added to household expenses.

Budgetary Constraints and Expert Predictions

The administration will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much scope there is for such measures.

The consensus from most analysts is that Reeves will have to announce tax increases or expenditure reductions in order to meet her voluntary borrowing rules.

Earlier on the same day, calculations suggested there was a twenty-two billion pound gap for the chancellor to fill, which is at the more modest range of projections.

"It is a collective responsibility between the central bank and the administration to bear down further on some of the causes of inflation," the Chancellor stated to the BBC in the US capital, at the yearly gatherings of the IMF and World Bank.

Revenue Pledges and Global Concerns

While a great deal of the focus has been on likely tax increases, the chancellor said the most recent data from the OBR had not changed her pledge to campaign commitments not to raise tax levels on income tax, VAT or social security contributions.

She attributed an "unpredictable world" with rising international and commercial concerns for the fiscal tax moves, likely to be directed on those "most able to pay."

Global Economic Disputes

Referring to apprehensions about the UK's trade ties with China she said: "The UK's national security always come first."

Last week's statement by Chinese authorities to increase trade restrictions on rare earths and other resources that are essential for advanced tech manufacturing led American leader Donald Trump to suggest an further 100% tariff on imports from China, raising the prospect of an full-scale commercial conflict between the two economic giants.

The American finance chief described the Chinese decision "commercial pressure" and "a international production control attempt."

Questioned on accepting the American proposal to participate in its dispute with the Asian nation, Reeves said she was "deeply worried" by China's actions and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the action was "harmful for the international commerce and creates further headwinds."

"In my view there are fields where we must address China, but there are also significant prospects to sell into China's economy, including financial services and other sectors of the economic system. We've got to get that balance correct."

The chancellor also affirmed she was collaborating with G7 counterparts "on our own essential resources approach, so that we are reduced dependence."

Health Service Medicine Costs and Investment

The Chancellor also acknowledged that the price the NHS pays for medicines could rise as a result of ongoing talks with the US government and its drugs companies, in return for lower tariffs and capital.

Some of the biggest global pharmaceutical manufacturers have said lately that they are either delaying or abandoning investments in the United Kingdom, with several attributing the modest returns they are obtaining.

Last month, the Science Minister said the price the NHS spends on drugs would must increase to prevent firms and drug research funding leaving the United Kingdom.

Reeves told media: "It has been observed as a result of the payment system, that clinical trials, innovative medicines have not been provided in the UK in the manner that they are in other continental states."

"The objective is to ensure that individuals receiving treatment from the National Health Service are able to access the best critical drugs in the globe. And so we are reviewing this situation, and... looking to secure additional capital into Britain."